SEARCH   
MEMBER LOGIN    

Pharmaceutical Manufacturing in China: Market Research Report

Market Research • Market Size • Industry Statistics • Industry Analysis • Industry Trends

Pharmaceutical Manufacturing Market Research Report | Jan 2014

IBISWorld’s Pharmaceutical Manufacturing market research report is a comprehensive guide to market size and growth prospects. Our industry reports offer strategic industry analysis of the factors influencing companies, including new product developments, economic, lifestyle and demographic influences, distribution and supply chain factors and pricing issues. Full analysis accompanies our data forecasts to illustrate how the market responds to emerging industry trends.

Report Snapshot
Industry Statistics & Market Size
Revenue
$94bn
Annual Growth 08-13
18.8%
Annual Growth 13-18
Add to Cart
Profit
Add to Cart
Employment
602,031
Businesses
1,417
Industry Analysis & Industry Trends

In 2013, revenue for the Pharmaceutical Manufacturing industry is expected to total $94.4 billion, up 14.5% from 2012. This represents an annualized growth rate of 18.8% since 2008. The industry's profitability has also been increasing – from 10.3% of industry revenue in 2008 to 10.9% in 2013. There are about 1,417 industry enterprises in 2013, employing about 602,031 people with a payroll of about $5.8 billion.

Hospitals are currently the main distribution channel for medicines produced by this industry. However, upcoming healthcare reforms will enable drugstores to become the major distribution channel in the near future. In the past, many consumers could not afford to purchase medicine or see a doctor.... purchase to read more

Industry Report - Starting a New Business Chapter

Substantial barriers to entry to the industry exist as globalized players continue their development in China. The top 20 globalized pharmaceutical companies have established manufacturing companies in China as either joint ventures or solely foreign-owned enterprises. Some of these companies, such as GSK, Roche, Novo Nordisk, AstraZeneca and Eli Lilly & Company, have also set up R&D centers in China. Further, some domestic companies, particularly the major players within this industry, also have significant market strengths on a local basis.

China is a major manufacturing center for generic drugs. With numerous pharmaceuticals having long patent times, almost all of which are from foreign companies, this is a major barrier for new firms to enter the industry... purchase to read more

 


Industry ProductsRelated ReportsTable of Contents

What is the Pharmaceutical Manufacturing Industry?

The Pharmaceutical Manufacturing Industry in China is primarily engaged in the manufacture of chemical medicinal and pharmaceutical products in various formats, including ampoules, tablets, capsules, vials, ointments, powders, solutions, suspensions and radioactive medicine. These products are then sold via pharmacies or distributed via hospitals. Biological and veterinary medicine products are not included in this industry.

Industry Products
Over-the-counter pharmaceuticalsPatented prescription medicinesAnti-infective medicinesAntitumor medicinesNervous system medicinesCardiovascular system medicinesDigestive system medicinesOther prescription and generic medicines
 
Industry Activities
Anti-infective drugAntitumor drugdrugs acting on the nervous systemAntipyretic and analgesicCardiovascular system drugDigestive system drugRespiratory system drugHypoglycemic drugDrugs for family planning


View Sample
Quote
Select Clients